JAMA Patient Page February 17, 2015Pneumococcal Vaccination Jill Jin, MD, MPH Article Information JAMA. 2015;313(7):758. doi:10.1001/jama.2015.64 Español related articles icon Related Articles JAMA Clinical Guidelines Synopsis Use of Pneumococcal Vaccine in Adults Jennifer Pisano, MD; Adam S....
Logistic regression models assessed associations between vaccination, patient and practice characteristics. Annual pneumococcal vaccine uptake varied by patient's age (65–74 or ≥75years), presence of comorbidities and regularity of practice visits (range 36% to 76%), and it declined slowly from ...
Adults need one dose of the vaccine.Detailed Vaxneuvance dosage information Vaxneuvance side effectsThe most common side effects in children less than 2 years of age include:Fever Pain, redness, swelling, or a lump where your child got the injection More fussy than usual • More sleepy ...
A physician, nurse, pharmacist, or health department should file a Vaccine Adverse Event Reporting System form, or if necessary, the patient can self-report the event (see RESOURCES SIDEBAR).2,3,7 Vaccine Information Statements Vaccine Information Statements (VISs) are information sheets produced ...
Vaccination with VAXNEUVANCE may not protect all vaccine recipients. Before administering VAXNEUVANCE, please read the accompanyingPrescribing Information. ThePatient Informationalso is available. Select Safety Information for PNEUMOVAX 23 Do not administerPNEUMOVAX 23to individuals with a history of a hy...
The Patient Information also is available. Select Safety Information for PNEUMOVAX 23 Do not administer PNEUMOVAX 23 to individuals with a history of a hypersensitivity reaction to any component of the vaccine. Defer vaccination with PNEUMOVAX 23 in persons with moderate or severe acute illness. ...
To the Editor.—Pneumococcal vaccine has been used to protect high-risk individuals from pneumococcal infection.1 Both local and systemic adverse reactions
For immunocompromised patients, revaccination should be given 5 years after the first dose if the patient is older than 10 years and 3 years after the first dose if the patient is younger than 10 years. Conjugated Vaccine A seven-valent pneumococcal conjugate vaccine (Prevenar, Wyeth-Lederle) ...
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The American Lung...
PREVNAR 20Ⓡ (Pneumococcal 20-valent Conjugate Vaccine) IMPORTANT SAFETY INFORMATION FOR PREVNAR 20 Prevnar 20 should not be given to anyone who has had a severe allergic reaction to any component of Prevnar 20 or to diphtheria toxoid. Individuals with weakened immune systems may have a lower...